Mobilizing white blood cells to the lung: New discovery could lead to an improved influenza vaccine

July 10, 2008

Findings just published in the scientific journal Immunity by researchers at the Trudeau Institute shed new light on how a previously-unknown messaging mechanism within the human immune system prompts specific influenza-fighting cells to the lung airways during an infection.

Infections from the influenza virus are responsible for hundreds of thousands of hospitalizations and as many as 40,000 deaths in the United States each year. Although researchers have known for some time that white blood cells congregating in the lung and directly attacking the virus play an important role in defending against influenza, it has never been clear how exactly these white blood cells know when they are required in the lung.

Now new research in the Trudeau Institute laboratory of Dr. David Woodland offers important insights into the navigational aids used by these cells as they maneuver through the human body. Trudeau investigators have shown that lungs which have been infected with the influenza virus produce a series of chemicals, or chemokines, which act as beacons for specific types of white blood cells. While circulating in the bloodstream, these white blood cells recognize the chemical messages signaling the presence of the virus and the need for them to move into lung tissues.

According to Dr. Woodland, director of the Trudeau Institute and lead researcher on the project: “An important aspect of these findings is that this response occurs early in the disease process, typically within a couple of days of the initial infection. It also turns out that only a fraction of the available white blood cells are capable of recognizing these chemokine messages. Discovering that this response occurs rapidly, and that only a specific subset of white blood cells can recognize these messages, helps provide important new information for researchers working towards developing better a better influenza vaccine.”

The research paper, “The Chemokine Receptor CCR5 Plays a Key Role in the Early Memory CD8? T Cell Response to Respiratory Virus Infections,” is available in its entirety in Immunity.

Source: Trudeau Institute


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4 /5 (1 vote)


July 10, 2008 all stories

Comments: 0

4 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • New cancer target for non-Hodgkin's lymphoma
    created Nov 22, 2009 | popularity not rated yet | comments 0
  • Scientists find new link between insulin and core body temperature
    created Nov 19, 2009 | popularity not rated yet | comments 0
  • Secondhand smoke exposure worse for toddlers, obese children
    created Nov 18, 2009 | popularity not rated yet | comments 0
  • Cross-country runabouts -- immune cells on the move
    created Nov 17, 2009 | popularity not rated yet | comments 0
  • Scientists discover cells that control inflammation in chronic disease
    created Nov 17, 2009 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

Other News

Overeating can set stage for obesity, researchers say

Medicine & Health / Health

created 23 hours ago | popularity 5 / 5 (1) | comments 2

It doesn't seem like a fair fight. In one corner loomed the Thanksgiving table, groaning with poultry, pie and mashed potatoes.


What a grind: Bruxism at night likely a sign of stress by day

Medicine & Health / Health

created 18 hours ago | popularity 5 / 5 (1) | comments 0

You can practically track Steve Barkley's stress by the level of activity in his temporomandibular joint, or TMJ, the hinge joint that connects the lower jaw to the temporal bone of the skull and helps one chew, talk and ...


smoking, cigarette

Vaccine being developed to help smokers quit

Medicine & Health / Medications

created Nov 20, 2009 | popularity 4.5 / 5 (13) | comments 10

(PhysOrg.com) -- Glaxo-SmithKline has joined forces with Nabi Pharmaceuticals to produce a vaccine to help smokers give up their addiction permanently.


Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created Nov 25, 2009 | popularity 4.7 / 5 (23) | comments 7

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...


popcorn

Popcorn at the movies still an unhealthy treat

Medicine & Health / Health

created Nov 23, 2009 | popularity 4.5 / 5 (2) | comments 5

(PhysOrg.com) -- A study carried out in 1994 by advocacy group CSPI (Center for Science in the Public Interest) found that popcorn being sold by cinema chains in the US was high in saturated fat and calories, ...